Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Medexus Pharmaceuticals Inc
T.MDP
Alternate Symbol(s):
MEDXF
Healthcare
Medexus Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company with a North American commercial platform. The Company has a portfolio of rare disease treatment solutions. Its focus is on the therapeutic areas of oncology, hematology, rheumatology, autoimmune diseases, allergy, and dermatology. It operates through two segments: Medexus Pharma Canada and Medexus Pharma USA. Its...
lead products are IXINITY (US), Rupall (Canada), Rasuvo (US) and Metoject (Canada), and Gleolan (US). IXINITY (US) is an intravenous recombinant factor IX therapeutic for use in patients with hemophilia B. Rupall (Canada) is a prescription allergy medication with a mode of action. Rasuvo (US) and Metoject (Canada) is a formulation of methotrexate designed to treat rheumatoid arthritis and other autoimmune diseases. Gleolan (US) is an optical imaging agent indicated in patients with glioma as an adjunct for the visualization of malignant tissue during surgery.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:MDP)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Sep 05, 2023 6:41pm
New Press Release - Medexus Pharmaceuticals Announces C$10 Million Bought-Deal Public Offering of Units
TORONTO and CHICAGO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. ("Medexus" or the "Company") (TSX: MDP) (OTCQX: MEDXF), is pleased to announce that it has entered into an agreement with Research Capital Corporation, as sole bookrunner and sole underwriter (the “Underwriter”),...
read article.
(38)
•••
Rockafellow2
X
View Profile
View Bullboard History
Post by
Rockafellow2
on Sep 05, 2023 2:19pm
In the event we elect to do so ...
Sounds like 'a maybe' to me ... Why can't they just say, that is what we are going to do ... Maybe cancel the debt if we elect to do so ... Sounds fishy to me fokes!
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 24, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Sep 05, 2023 7:31am
New Press Release - Medexus Strengthens Balance Sheet with US$18 Million Commitment Under Accordion Facility
Medexus expects net proceeds, together with projected cash on hand, to fully satisfy convertible debentures in cash at maturity in October 2023Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - September 5, 2023) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) today entered into an...
read article.
(2)
•••
ARP511
X
View Profile
View Bullboard History
Comment by
ARP511
on Aug 27, 2023 3:19pm
RE:RE:News coming soon?
Awaiting tow important news.. one from US FDA and one from Health Canada.. I am LONG, looking for SP of $6+
(3572)
•••
nozzpack
X
View Profile
View Bullboard History
Comment by
nozzpack
on Aug 23, 2023 1:17pm
RE:News coming soon?
Very strong volumes today....somethings on the way..
(2)
•••
ARP511
X
View Profile
View Bullboard History
Post by
ARP511
on Aug 22, 2023 4:33pm
News coming soon?
Much awaited news from Health Canada on topical antifungal product may be coming! Staying long, hope to see $4+ soon.
(3572)
•••
nozzpack
X
View Profile
View Bullboard History
Post by
nozzpack
on Aug 18, 2023 7:10am
Very Significant Development News
Medexus presents phase 3/4 study data for Ixinity 2023-08-17 17:41 ET - News Release Mr. Ken d'Entremont reports MEDEXUS STUDY SUPPORTS EFFICACY AND SAFETY OF
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Aug 17, 2023 5:31pm
New Press Release - Medexus Study Supports Efficacy and Safety of IXINITY in Pediatric Patients with Severe or Moderately Severe Hemophilia B
Poster presentation at National Hemophilia Foundation (NHF) Bleeding Disorders Conference 2023 highlights effective prophylaxis, control of bleeding episodes, and consistent safety profilePhase 3/4 data presentation follows FDA acceptance for review of IXINITY® supplemental Biological License...
read article.
(2)
•••
ARP511
X
View Profile
View Bullboard History
Comment by
ARP511
on Aug 17, 2023 11:52am
RE:Pure manipulation
Happy to see an uptrend..
(2)
•••
ARP511
X
View Profile
View Bullboard History
Post by
ARP511
on Aug 16, 2023 4:06pm
Pure manipulation
Someone is frantically trying to get the SP down drastically (not in line with market) and may know something. Folks, we are anticipating the approval of the nail laquer product from Health Canada
...more
(4)
•••
Paparico1
X
View Profile
View Bullboard History
Comment by
Paparico1
on Aug 15, 2023 2:55pm
RE:RE:Shorts
On 900 shares lol You probably the person who believes government should ban shorting. If I short, would only be on options and Mdp has no options. shorters balance the market, any smart
...more
(3572)
•••
nozzpack
X
View Profile
View Bullboard History
Comment by
nozzpack
on Aug 15, 2023 11:37am
RE:Shorts
You must be the chap fitting meaningless technical signals on such a lightly traded stock. Your posts always talks about pullbacks so, you are the shorter..
(3572)
•••
nozzpack
X
View Profile
View Bullboard History
Post by
nozzpack
on Aug 15, 2023 11:34am
CEO Webinair
The link is below and very much worth listening to, as we have a very bright future that should sustain our 25% growth per year . Verging on $200 m cad in sales with a market cap of $55 million, it
...more
(4)
•••
Paparico1
X
View Profile
View Bullboard History
Post by
Paparico1
on Aug 14, 2023 8:25pm
Shorts
I personally don't like stocks with extremely low shorts. Last time shorts this low, MDP, July 30 2021 was 1.606 shares. Stock fell July 27 of 7.90 to Aug 3 2021 of 4.71. We are at 946 shares
...more
(3572)
•••
nozzpack
X
View Profile
View Bullboard History
Post by
nozzpack
on Aug 13, 2023 6:58pm
Getting the Share Price to $6.30
That is the conversion price of the Convertible Debenture due in early Oct of 2023. Removing this drag on our balance sheet would do wonders for the balance sheet and net margins. Tomorrow May be
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >